Onur Bas

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country.

Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country.

Journal: Expert review of anticancer therapy

Published: July 04, 2025

Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors.

Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors.

Journal: Immunotherapy

Published: June 05, 2025

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study.

Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study.

Journal: Scientific reports

Published: April 04, 2025

Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience.

Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience.

Journal: Journal of clinical medicine

Published: February 26, 2025

Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors.

Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors.

Journal: Expert review of anticancer therapy

Published: February 24, 2025

Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer.

Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer.

Journal: Journal of clinical medicine

Published: February 20, 2025

Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis.

Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis.

Journal: The oncologist

Published: January 30, 2025

The association between HALP score and survival in patients treated with immune checkpoint inhibitors.

The association between HALP score and survival in patients treated with immune checkpoint inhibitors.

Journal: Expert review of anticancer therapy

Published: January 08, 2025

Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysis.

Prognostic significance of the cachexia index (CXI) in patients with cancer: A systematic review and meta-analysis.

Journal: Clinical nutrition ESPEN

Published: November 21, 2024

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.

Journal: Scientific reports

Published: November 05, 2024

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience.

Journal: BMC cancer

Published: September 20, 2024

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study.

Journal: Cancers

Published: May 04, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026